Wellgistics Health Files Q2 2025 Report

Ticker: WGRX · Form: 10-Q · Filed: Aug 19, 2025 · CIK: 2030763

Sentiment: neutral

Topics: quarterly-report, sec-filing, financials

Related Tickers: WGRX

TL;DR

WGRX filed its 10-Q for Q2 2025. All systems go.

AI Summary

Wellgistics Health, Inc. filed its quarterly report for the period ended June 30, 2025. The company's common stock trades under the symbol WGRX on The Nasdaq Stock Market LLC. This filing indicates the company is subject to the reporting requirements of the Securities Exchange Act of 1934.

Why It Matters

This filing provides investors with an update on Wellgistics Health's financial performance and operational status for the second quarter of 2025.

Risk Assessment

Risk Level: low — This is a standard quarterly filing and does not contain immediate red flags or significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 10-Q filing?

The Form 10-Q is a quarterly report required by the Securities and Exchange Commission for companies to disclose their financial and operational performance for the quarterly period ended June 30, 2025.

What is the trading symbol for Wellgistics Health, Inc. and where is it traded?

The trading symbol for Wellgistics Health, Inc. is WGRX, and its common stock is registered on The Nasdaq Stock Market LLC.

Has Wellgistics Health, Inc. filed all required reports for the preceding 12 months?

The filing indicates 'Yes' to having filed reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months.

Has Wellgistics Health, Inc. submitted all required Interactive Data Files?

The filing indicates 'Yes' to having submitted every Interactive Data File required pursuant to Rule 405 of Regulation S-T during the preceding 12 months.

What is the principal executive office address for Wellgistics Health, Inc.?

The principal executive offices are located at 3000 Bayport Drive, Suite 950, Tampa, Florida 33607.

Filing Stats: 4,418 words · 18 min read · ~15 pages · Grade level 17.1 · Accepted 2025-08-19 17:25:21

Key Financial Figures

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 39 Item 4.

Controls and Procedures

Controls and Procedures 39

Other Information

Part II. Other Information 40 Item 1

Legal Proceedings

Legal Proceedings 40 Item 1A

Risk Factors

Risk Factors 40 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 40 Item 3 Defaults Upon Senior Securities 40 Item 4 Mine Safety Disclosures 40 Item 5 Other Information 40 Item 6 Exhibits 41

Signatures

Signatures 42 In this Quarterly Report on Form 10-Q (this " Quarterly Report "), all references to "Wellgistics Health, Inc.," "Wellgistics Health," "we," "us," "our" or the "Company" mean Wellgistics Health, Inc., and its wholly-owned subsidiaries, except where it is made clear that the term means only Wellgistics Health, Inc. The Company's common stock, par value $0.0001 per share, is referred to as "common stock." 2 PART I—FINANCIAL INFORMATION Item 1. Financial Statements. WELLGISTICS HEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) June 30, December 31, 2025 2024 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 419,942 $ 1,028,336 Accounts receivable, related party 775,027 271,298 Accounts receivable, net 1,386,423 2,453,517 Inventories, net 9,031,143 9,518,608 Prepaid expenses 65,525 524 Due from related parties 1,249,888 1,021,000 Subscription receivable 581,695 - Deferred offering costs - 875,385 Total current assets 13,509,643 15,168,668 Property, plant and equipment, net 308,642 388,180 Capitalized software 2,023,076 1,618,017 Operating lease, right-of-use-assets 1,280,459 1,528,128 Goodwill 16,219,929 16,219,929 Other intangible assets, net 19,219,880 20,746,009 Note receivable 139,771 139,771 Other assets 1,438,607 1,438,940 Deposits 85,008 85,008 Total assets $ 54,225,015 $ 57,332,650 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 9,450,651 $ 6,308,754 Accounts payable, related party 25,500 25,500 Accounts payable 25,500 25,500 Accrued expenses and other current liabilities 5,466,166 4,320,417 Due to related parties 5,234,770 4,944,770 Due to seller 8,500,000 10,000,000 Due to related parties 5,234,770 4,944,770 Current portion of debt obligations, net of debt discount 13,180,200 11,927,816 Operating lease liabilities- current portion 546,255 519,490 Total

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing